Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/molnlycke-health-care-announces-us-15m-investment-in-next-generation-enzymatic-therapeutics-company-mediwound-ltd-302196800.html
en | boerse | 67933093 |
